BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34334770)

  • 1. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting.
    Okayama S; Matsuda Y
    J Hosp Palliat Nurs; 2021 Dec; 23(6):539-543. PubMed ID: 34334770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of Opioid Switching to Methadone for Cancer Pain Control in Successful and Unsuccessful Cases.
    Okayama S; Matsuda Y; Yoshikawa Y
    J Palliat Med; 2019 Jul; 22(7):844-847. PubMed ID: 30716000
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
    Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
    Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to "A better interpretation of data regarding the opioid switching to methadone".
    Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
    BMC Palliat Care; 2023 Jun; 22(1):66. PubMed ID: 37280625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
    Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
    J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
    Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
    Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.
    Juba KM; Khadem TM; Hutchinson DJ; Brown JE
    J Palliat Med; 2017 Jul; 20(7):722-728. PubMed ID: 28186837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes, Beliefs, and Practices of Pediatric Palliative Care Physicians Regarding the Use of Methadone in Children With Advanced Cancer.
    Madden K; Liu D; Bruera E
    J Pain Symptom Manage; 2019 Feb; 57(2):260-265. PubMed ID: 30447383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
    Khoo SY; Aziz FA; Nambbiar P
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone switching for refractory cancer pain.
    Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
    BMC Palliat Care; 2022 Nov; 21(1):191. PubMed ID: 36324113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
    Mercadante S; Cascio AL; Casuccio A
    J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practices, Attitudes, and Beliefs of Palliative Care Physicians Regarding the Use of Methadone and Other Long-Acting Opioids in Children with Advanced Cancer.
    Madden K; Park M; Liu D; Bruera E
    J Palliat Med; 2018 Oct; 21(10):1408-1413. PubMed ID: 29893627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of QTc Interval Prolongation Among Patients With Cancer Using Enteral Methadone.
    Lovell AG; Protus BM; Saphire ML; Kale SS; Lehman A; Hartman A
    Am J Hosp Palliat Care; 2019 Mar; 36(3):177-184. PubMed ID: 30428683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Low-Dose Methadone as Add-On to Regular Opioid Therapy in Cancer-Related Pain at End of Life: A National Swedish Survey in Specialized Palliative Care.
    Fürst P; Lundström S; Klepstad P; Strang P
    J Palliat Med; 2020 Feb; 23(2):226-232. PubMed ID: 31436477
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study.
    Hayes J; Waldron D; Levins KJ; Gaffney L; Azhar M; Beatty S; Mannion E
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e839-e842. PubMed ID: 36104162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Start-Low, Go-Slow Methadone Initiation for Cancer-Related Pain: What's the Hurry?
    Hawley P; Chow L; Fyles G; Shokoohi A; O'Leary MJ; Mittelstadt M
    J Palliat Med; 2017 Nov; 20(11):1244-1251. PubMed ID: 28595027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of methadone in cancer-induced bone pain: a retrospective cohort study.
    Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N
    Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.